Literature DB >> 18174230

Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus.

H Miyagawa1, M Yamai, D Sakaguchi, C Kiyohara, H Tsukamoto, Y Kimoto, T Nakamura, J-H Lee, C-Y Tsai, B-L Chiang, T Shimoda, M Harada, T Tahira, K Hayashi, T Horiuchi.   

Abstract

OBJECTIVE: Identification of the genes responsible for systemic lupus erythematosus (SLE).
METHODS: All the exons and putative promoter regions of 53 candidate genes (TNFRSF6/Fas, TNFSF6/FasL, Fli1, TNFSF10/TRAIL, TNFSF12/TWEAK, Bcl-2, PTEN, FADD, TRADD, CDKN1A, TNFRSF1A/TNFR1, TNFRSF4/OX40, TNFSF4/OX40L, TNFSF5/CD40L, TNFSF13B/BAFF, ICOS, CTLA4, CD28, FYN, G2A, CR2, PTPRC/CD45, CD22, CD19, Lyn, PDCD1, PTPN6, TGFB1, TGFB2, TGFB3, TGFBR1, TGFBR2, TGFBR3, CD3Z, DNASE1, APCS, MERTK, C3, C1QA, C1QB, C1QG, C2, MBL2, IGHM, IL-2, IL-4, IL-10, IFNG, TNFA, MAN2A1, TNFRSF11A/RANK, TNFRSF11B/OPG, TNFSF11/OPGL) were screened for single nucleotide polymorphisms (SNPs) and their association with SLE was assessed by case-control studies. A total of 509 cases and 964 controls of Japanese descent were enrolled.
RESULTS: A total of 316 SNPs was identified. When analysed in the Japanese population, the allele frequencies of T at rs7951 and G at rs2230201 of the C3 gene were 0.110 and 0.626, respectively, in SLE patients; significantly higher than the frequencies of 0.081 and 0.584, respectively, in controls [odds ratio (OR) = 1.40, 95% confidence interval (CI) = 1.05-1.86, P = 0.016 and OR=1.19, 95% CI = 1.01-1.41, P = 0.038, respectively]. The mean serum C3 level of carriers of the rs7951 T allele was significantly lower than that of non-carriers of the T allele in 87 SLE patients whose medical records were available (P = 0.0018).
CONCLUSION: rs7951 T allele of the C3 gene was significantly associated with SLE, and decreased serum level of C3 seems to be correlated with this allele.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174230     DOI: 10.1093/rheumatology/kem321

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  27 in total

1.  Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis.

Authors:  Liu Zhi-Chun; Zhou Qiao-Ling; Liu Zhi-Qin; Li Xiao-Zhao; Zuo Xiao-xia; Tang Rong
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  Complement components 2 and 7 (C2 and C7) gene polymorphisms are not major risk factors for SLE susceptibility in the Malaysian population.

Authors:  Lay-Hoong Lian; Ai-Sze Ching; Zheng-Yi Chong; Kek-Heng Chua
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

3.  Allelic variants of complement genes associated with dense deposit disease.

Authors:  Maria Asuncion Abrera-Abeleda; Carla Nishimura; Kathy Frees; Michael Jones; Tara Maga; Louis M Katz; Yuzhou Zhang; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

4.  Association of killer cell immunoglobulin-like receptor and human leucocyte antigen-Cw gene combinations with systemic lupus erythematosus.

Authors:  Y Hou; C Zhang; D Xu; H Sun
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

Review 5.  Signaling mechanisms regulating B-lymphocyte activation and tolerance.

Authors:  Elias Hobeika; Peter J Nielsen; David Medgyesi
Journal:  J Mol Med (Berl)       Date:  2015-01-29       Impact factor: 4.599

6.  Complement component 3: characterization and association with mastitis resistance in Egyptian water buffalo and cattle.

Authors:  Nermin El-Halawany; Shawky A Abd-El-Monsif; F M Al-Tohamy Ahmed; Lamees Hegazy; Hamdy Abdel-Shafy; Magdy A Abdel-Latif; Yasser A Ghazi; Christiane Neuhoff; Dessie Salilew-Wondim; Karl Schellander
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

Review 7.  Pathways: Strategies for susceptibility genes in SLE.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Autoimmun Rev       Date:  2010-02-08       Impact factor: 9.754

8.  CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia.

Authors:  Fatih M Uckun; Patricia Goodman; Hong Ma; Ilker Dibirdik; Sanjive Qazi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-14       Impact factor: 11.205

Review 9.  The genetics and epigenetics of autoimmune diseases.

Authors:  Anura Hewagama; Bruce Richardson
Journal:  J Autoimmun       Date:  2009-04-05       Impact factor: 7.094

10.  Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing.

Authors:  K B Douglas; D C Windels; J Zhao; A V Gadeliya; H Wu; K M Kaufman; J B Harley; J Merrill; R P Kimberly; G S Alarcón; E E Brown; J C Edberg; R Ramsey-Goldman; M Petri; J D Reveille; L M Vilá; P M Gaffney; J A James; K L Moser; M E Alarcón-Riquelme; T J Vyse; G S Gilkeson; C O Jacob; J T Ziegler; C D Langefeld; D Ulgiati; B P Tsao; S A Boackle
Journal:  Genes Immun       Date:  2009-04-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.